SCHEMBL20142848

SCHEMBL20142848

CN(C)c1nc(Nc2ccc(CO)cc2)sc1C(=O)c1ccc(C#N)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 2/20 0.58
GSK3B P49841 2/20 0.58
CCNA2 P20248 4/20 0.48
CDK2 P24941 4/20 0.48
ADORA3 P0DMS8 6/20 0.45
NPC1 O15118 5/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
RAB9A P51151 3/20 0.41
MAPT P10636 3/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
ADORA2A P29274 4/20 0.40
ADORA1 P30542 4/20 0.40
CDK5 Q00535 4/20 0.39
CDK5R1 Q15078 4/20 0.39
LMNA P02545 1/20 0.39
MAPK14 Q16539 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ADORA2B P29275 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20142448 0.89 GSK3A (0.73) GSK3AGSK3BCCNA2CDK2ADORA3
SCHEMBL20142461 0.87 MEN1 (0.59) GSK3AGSK3BCCNA2CDK2ADORA3
SCHEMBL20142298 0.84 GSK3A (0.77) GSK3AGSK3BCCNA2CDK2NPC1
SCHEMBL20142401 0.84 GSK3A (0.58) GSK3AGSK3BCCNA2CDK2ADORA3
SCHEMBL20141907 0.82 GSK3A (0.54) GSK3AGSK3BCCNA2CDK2ADORA3
SCHEMBL20142859 0.81 GSK3A (0.47) GSK3AGSK3BCCNA2CDK2ADORA3
SCHEMBL20142492 0.81 GSK3A (0.57) GSK3AGSK3BCCNA2CDK2ADORA3
SCHEMBL20142475 0.78 GSK3A (0.48) GSK3AGSK3BCCNA2CDK2ADORA3
SCHEMBL20142429 0.77 GSK3A (0.78) GSK3AGSK3BCCNA2CDK2NPC1
SCHEMBL20142835 0.77 GSK3A (0.57) GSK3AGSK3BCCNA2CDK2ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089902-A1 DIAMINOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE APOGEE BIOTECHNOLOGY CORPORATION (US) 2018-05-17 WO disclosed